Teladoc Health (NYSE:TDOC) Reaches New 1-Year Low at $14.30

Teladoc Health, Inc. (NYSE:TDOCGet Free Report)’s share price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $14.30 and last traded at $14.50, with a volume of 1841108 shares changing hands. The stock had previously closed at $15.00.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on TDOC. Royal Bank of Canada lowered their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, February 21st. DA Davidson lowered their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Barclays lowered their price objective on shares of Teladoc Health from $26.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 21st. SVB Leerink assumed coverage on shares of Teladoc Health in a research note on Monday, February 26th. They issued a “market perform” rating and a $17.00 price objective on the stock. Finally, Piper Sandler lowered their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 21st. Ten investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and an average price target of $23.44.

Check Out Our Latest Stock Analysis on Teladoc Health

Teladoc Health Trading Down 1.7 %

The stock has a market cap of $2.46 billion, a price-to-earnings ratio of -10.86 and a beta of 0.94. The business’s fifty day simple moving average is $19.85 and its 200 day simple moving average is $19.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47.

Teladoc Health (NYSE:TDOCGet Free Report) last posted its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The company had revenue of $660.50 million for the quarter, compared to analysts’ expectations of $670.79 million. During the same period last year, the business posted ($0.23) earnings per share. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. On average, research analysts predict that Teladoc Health, Inc. will post -1.09 EPS for the current year.

Insiders Place Their Bets

In other news, Director Karen L. Daniel sold 14,073 shares of the company’s stock in a transaction dated Wednesday, December 20th. The stock was sold at an average price of $21.41, for a total value of $301,302.93. Following the transaction, the director now owns 36,995 shares in the company, valued at approximately $792,062.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Teladoc Health news, Director Karen L. Daniel sold 14,073 shares of the stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $21.41, for a total transaction of $301,302.93. Following the transaction, the director now owns 36,995 shares in the company, valued at $792,062.95. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Michael Willem Waters sold 4,523 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $86,751.14. Following the transaction, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 55,660 shares of company stock worth $1,177,416. 1.63% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC bought a new stake in shares of Teladoc Health in the first quarter valued at approximately $27,000. Dark Forest Capital Management LP increased its stake in shares of Teladoc Health by 408.2% in the first quarter. Dark Forest Capital Management LP now owns 1,245 shares of the health services provider’s stock valued at $32,000 after buying an additional 1,000 shares in the last quarter. Tyler Stone Wealth Management acquired a new stake in shares of Teladoc Health in the second quarter valued at $33,000. Hexagon Capital Partners LLC increased its position in Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after purchasing an additional 1,065 shares during the period. Finally, Quarry LP acquired a new stake in Teladoc Health in the first quarter worth about $35,000. Institutional investors and hedge funds own 77.07% of the company’s stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.